N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors

A variety of N-(2-amino-phenyl)-4-(heteroarylmethyl)-benzamides of general structure 10 were designed, synthesized, and evaluated as histone deacetylase (HDAC) inhibitors. A variety of N-(2-amino-phenyl)-4-(heteroarylmethyl)-benzamides were designed and synthesized. These compounds were shown to inh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2007-12, Vol.17 (24), p.6729-6733
Hauptverfasser: Vaisburg, Arkadii, Paquin, Isabelle, Bernstein, Naomy, Frechette, Sylvie, Gaudette, Frederic, Leit, Silvana, Moradei, Oscar, Raeppel, Stephane, Zhou, Nancy, Bouchain, Giliane, Woo, Soon Hyung, Jin, Zhiyun, Gillespie, Jeff, Wang, James, Fournel, Marielle, Yan, Pu Theresa, Trachy-Bourget, Marie-Claude, Robert, Marie-France, Lu, Aihua, Yuk, Jimmy, Rahil, Jubrail, MacLeod, A. Robert, Besterman, Jeffrey M., Li, Zuomei, Delorme, Daniel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6733
container_issue 24
container_start_page 6729
container_title Bioorganic & medicinal chemistry letters
container_volume 17
creator Vaisburg, Arkadii
Paquin, Isabelle
Bernstein, Naomy
Frechette, Sylvie
Gaudette, Frederic
Leit, Silvana
Moradei, Oscar
Raeppel, Stephane
Zhou, Nancy
Bouchain, Giliane
Woo, Soon Hyung
Jin, Zhiyun
Gillespie, Jeff
Wang, James
Fournel, Marielle
Yan, Pu Theresa
Trachy-Bourget, Marie-Claude
Robert, Marie-France
Lu, Aihua
Yuk, Jimmy
Rahil, Jubrail
MacLeod, A. Robert
Besterman, Jeffrey M.
Li, Zuomei
Delorme, Daniel
description A variety of N-(2-amino-phenyl)-4-(heteroarylmethyl)-benzamides of general structure 10 were designed, synthesized, and evaluated as histone deacetylase (HDAC) inhibitors. A variety of N-(2-amino-phenyl)-4-(heteroarylmethyl)-benzamides were designed and synthesized. These compounds were shown to inhibit recombinant human HDAC1 with IC 50 values in the sub-micromolar range. In human cancer cells growing in culture these compounds induced hyperacetylation of histones, induced the expression of the tumor suppressor protein p21 WAF1/Cip1, and inhibited cellular proliferation. Certain compounds of this class also showed in vivo activity in various human tumor xenograft models in mice.
doi_str_mv 10.1016/j.bmcl.2007.10.050
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68507276</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X0701219X</els_id><sourcerecordid>68507276</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-3369f526bc6fadcdc2f5fa46f5b25f3722f901a3107bb8dcdbe23015a6945d823</originalsourceid><addsrcrecordid>eNqFkEtr3DAUhUVpaCZp_0AXxZuGdKGpJOsxgm5C6AtCumkhOyHJV1iDLU8lT8rk11dmBrJrVxcO3zlcPoTeUrKmhMqP27Ub_bBmhKgarIkgL9CKcslxy4l4iVZES4I3mj-co4tStoRQTjh_hc6p0kopJlfo4R5fM3wzxjThXQ_pMHzAHF_3MEOebD4MI8z9EjpIT3aMHZTGlibBn6aPZZ4SNB1YD_NhsAWamPro4jzl8hqdBTsUeHO6l-jXl88_b7_hux9fv9_e3GHPqZhx20odBJPOy2A733kWRLBcBuGYCK1iLGhCbUuJcm5TAQesJVRYqbnoNqy9RFfH3V2efu-hzGaMxcMw2ATTvhi5EUQxJf8LUq2obmVbQXYEfZ5KyRDMLsexujCUmEW82ZpFvFnEL1kVX0vvTut7N0L3XDmZrsD7E2CLt0PINvlYnjktNZFSVO7TkYMq7TFCNsVHSB66mMHPppviv_74CyWroR4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19719363</pqid></control><display><type>article</type><title>N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Vaisburg, Arkadii ; Paquin, Isabelle ; Bernstein, Naomy ; Frechette, Sylvie ; Gaudette, Frederic ; Leit, Silvana ; Moradei, Oscar ; Raeppel, Stephane ; Zhou, Nancy ; Bouchain, Giliane ; Woo, Soon Hyung ; Jin, Zhiyun ; Gillespie, Jeff ; Wang, James ; Fournel, Marielle ; Yan, Pu Theresa ; Trachy-Bourget, Marie-Claude ; Robert, Marie-France ; Lu, Aihua ; Yuk, Jimmy ; Rahil, Jubrail ; MacLeod, A. Robert ; Besterman, Jeffrey M. ; Li, Zuomei ; Delorme, Daniel</creator><creatorcontrib>Vaisburg, Arkadii ; Paquin, Isabelle ; Bernstein, Naomy ; Frechette, Sylvie ; Gaudette, Frederic ; Leit, Silvana ; Moradei, Oscar ; Raeppel, Stephane ; Zhou, Nancy ; Bouchain, Giliane ; Woo, Soon Hyung ; Jin, Zhiyun ; Gillespie, Jeff ; Wang, James ; Fournel, Marielle ; Yan, Pu Theresa ; Trachy-Bourget, Marie-Claude ; Robert, Marie-France ; Lu, Aihua ; Yuk, Jimmy ; Rahil, Jubrail ; MacLeod, A. Robert ; Besterman, Jeffrey M. ; Li, Zuomei ; Delorme, Daniel</creatorcontrib><description>A variety of N-(2-amino-phenyl)-4-(heteroarylmethyl)-benzamides of general structure 10 were designed, synthesized, and evaluated as histone deacetylase (HDAC) inhibitors. A variety of N-(2-amino-phenyl)-4-(heteroarylmethyl)-benzamides were designed and synthesized. These compounds were shown to inhibit recombinant human HDAC1 with IC 50 values in the sub-micromolar range. In human cancer cells growing in culture these compounds induced hyperacetylation of histones, induced the expression of the tumor suppressor protein p21 WAF1/Cip1, and inhibited cellular proliferation. Certain compounds of this class also showed in vivo activity in various human tumor xenograft models in mice.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2007.10.050</identifier><identifier>PMID: 17977726</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Amination ; Animals ; Antineoplastic agents ; Benzamides ; Benzamides - chemistry ; Benzamides - pharmacology ; Binding Sites ; Biological and medical sciences ; Cancer cell proliferation ; Cell Line ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; General aspects ; HDAC ; Histone Deacetylase Inhibitors ; Histone Deacetylases - chemistry ; Histone Deacetylases - metabolism ; Humans ; Medical sciences ; Methylation ; Mice ; Models, Molecular ; Molecular Structure ; Niacin - pharmacology ; ortho-Aminobenzoates - chemistry ; Pharmacology. Drug treatments ; Structure-Activity Relationship ; Urea - chemistry ; Vasodilation - drug effects</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2007-12, Vol.17 (24), p.6729-6733</ispartof><rights>2007 Elsevier Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-3369f526bc6fadcdc2f5fa46f5b25f3722f901a3107bb8dcdbe23015a6945d823</citedby><cites>FETCH-LOGICAL-c415t-3369f526bc6fadcdc2f5fa46f5b25f3722f901a3107bb8dcdbe23015a6945d823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmcl.2007.10.050$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19690665$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17977726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vaisburg, Arkadii</creatorcontrib><creatorcontrib>Paquin, Isabelle</creatorcontrib><creatorcontrib>Bernstein, Naomy</creatorcontrib><creatorcontrib>Frechette, Sylvie</creatorcontrib><creatorcontrib>Gaudette, Frederic</creatorcontrib><creatorcontrib>Leit, Silvana</creatorcontrib><creatorcontrib>Moradei, Oscar</creatorcontrib><creatorcontrib>Raeppel, Stephane</creatorcontrib><creatorcontrib>Zhou, Nancy</creatorcontrib><creatorcontrib>Bouchain, Giliane</creatorcontrib><creatorcontrib>Woo, Soon Hyung</creatorcontrib><creatorcontrib>Jin, Zhiyun</creatorcontrib><creatorcontrib>Gillespie, Jeff</creatorcontrib><creatorcontrib>Wang, James</creatorcontrib><creatorcontrib>Fournel, Marielle</creatorcontrib><creatorcontrib>Yan, Pu Theresa</creatorcontrib><creatorcontrib>Trachy-Bourget, Marie-Claude</creatorcontrib><creatorcontrib>Robert, Marie-France</creatorcontrib><creatorcontrib>Lu, Aihua</creatorcontrib><creatorcontrib>Yuk, Jimmy</creatorcontrib><creatorcontrib>Rahil, Jubrail</creatorcontrib><creatorcontrib>MacLeod, A. Robert</creatorcontrib><creatorcontrib>Besterman, Jeffrey M.</creatorcontrib><creatorcontrib>Li, Zuomei</creatorcontrib><creatorcontrib>Delorme, Daniel</creatorcontrib><title>N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A variety of N-(2-amino-phenyl)-4-(heteroarylmethyl)-benzamides of general structure 10 were designed, synthesized, and evaluated as histone deacetylase (HDAC) inhibitors. A variety of N-(2-amino-phenyl)-4-(heteroarylmethyl)-benzamides were designed and synthesized. These compounds were shown to inhibit recombinant human HDAC1 with IC 50 values in the sub-micromolar range. In human cancer cells growing in culture these compounds induced hyperacetylation of histones, induced the expression of the tumor suppressor protein p21 WAF1/Cip1, and inhibited cellular proliferation. Certain compounds of this class also showed in vivo activity in various human tumor xenograft models in mice.</description><subject>Amination</subject><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Benzamides</subject><subject>Benzamides - chemistry</subject><subject>Benzamides - pharmacology</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Cancer cell proliferation</subject><subject>Cell Line</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>General aspects</subject><subject>HDAC</subject><subject>Histone Deacetylase Inhibitors</subject><subject>Histone Deacetylases - chemistry</subject><subject>Histone Deacetylases - metabolism</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Methylation</subject><subject>Mice</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Niacin - pharmacology</subject><subject>ortho-Aminobenzoates - chemistry</subject><subject>Pharmacology. Drug treatments</subject><subject>Structure-Activity Relationship</subject><subject>Urea - chemistry</subject><subject>Vasodilation - drug effects</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtr3DAUhUVpaCZp_0AXxZuGdKGpJOsxgm5C6AtCumkhOyHJV1iDLU8lT8rk11dmBrJrVxcO3zlcPoTeUrKmhMqP27Ub_bBmhKgarIkgL9CKcslxy4l4iVZES4I3mj-co4tStoRQTjh_hc6p0kopJlfo4R5fM3wzxjThXQ_pMHzAHF_3MEOebD4MI8z9EjpIT3aMHZTGlibBn6aPZZ4SNB1YD_NhsAWamPro4jzl8hqdBTsUeHO6l-jXl88_b7_hux9fv9_e3GHPqZhx20odBJPOy2A733kWRLBcBuGYCK1iLGhCbUuJcm5TAQesJVRYqbnoNqy9RFfH3V2efu-hzGaMxcMw2ATTvhi5EUQxJf8LUq2obmVbQXYEfZ5KyRDMLsexujCUmEW82ZpFvFnEL1kVX0vvTut7N0L3XDmZrsD7E2CLt0PINvlYnjktNZFSVO7TkYMq7TFCNsVHSB66mMHPppviv_74CyWroR4</recordid><startdate>20071215</startdate><enddate>20071215</enddate><creator>Vaisburg, Arkadii</creator><creator>Paquin, Isabelle</creator><creator>Bernstein, Naomy</creator><creator>Frechette, Sylvie</creator><creator>Gaudette, Frederic</creator><creator>Leit, Silvana</creator><creator>Moradei, Oscar</creator><creator>Raeppel, Stephane</creator><creator>Zhou, Nancy</creator><creator>Bouchain, Giliane</creator><creator>Woo, Soon Hyung</creator><creator>Jin, Zhiyun</creator><creator>Gillespie, Jeff</creator><creator>Wang, James</creator><creator>Fournel, Marielle</creator><creator>Yan, Pu Theresa</creator><creator>Trachy-Bourget, Marie-Claude</creator><creator>Robert, Marie-France</creator><creator>Lu, Aihua</creator><creator>Yuk, Jimmy</creator><creator>Rahil, Jubrail</creator><creator>MacLeod, A. Robert</creator><creator>Besterman, Jeffrey M.</creator><creator>Li, Zuomei</creator><creator>Delorme, Daniel</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20071215</creationdate><title>N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors</title><author>Vaisburg, Arkadii ; Paquin, Isabelle ; Bernstein, Naomy ; Frechette, Sylvie ; Gaudette, Frederic ; Leit, Silvana ; Moradei, Oscar ; Raeppel, Stephane ; Zhou, Nancy ; Bouchain, Giliane ; Woo, Soon Hyung ; Jin, Zhiyun ; Gillespie, Jeff ; Wang, James ; Fournel, Marielle ; Yan, Pu Theresa ; Trachy-Bourget, Marie-Claude ; Robert, Marie-France ; Lu, Aihua ; Yuk, Jimmy ; Rahil, Jubrail ; MacLeod, A. Robert ; Besterman, Jeffrey M. ; Li, Zuomei ; Delorme, Daniel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-3369f526bc6fadcdc2f5fa46f5b25f3722f901a3107bb8dcdbe23015a6945d823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Amination</topic><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Benzamides</topic><topic>Benzamides - chemistry</topic><topic>Benzamides - pharmacology</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Cancer cell proliferation</topic><topic>Cell Line</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>General aspects</topic><topic>HDAC</topic><topic>Histone Deacetylase Inhibitors</topic><topic>Histone Deacetylases - chemistry</topic><topic>Histone Deacetylases - metabolism</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Methylation</topic><topic>Mice</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Niacin - pharmacology</topic><topic>ortho-Aminobenzoates - chemistry</topic><topic>Pharmacology. Drug treatments</topic><topic>Structure-Activity Relationship</topic><topic>Urea - chemistry</topic><topic>Vasodilation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vaisburg, Arkadii</creatorcontrib><creatorcontrib>Paquin, Isabelle</creatorcontrib><creatorcontrib>Bernstein, Naomy</creatorcontrib><creatorcontrib>Frechette, Sylvie</creatorcontrib><creatorcontrib>Gaudette, Frederic</creatorcontrib><creatorcontrib>Leit, Silvana</creatorcontrib><creatorcontrib>Moradei, Oscar</creatorcontrib><creatorcontrib>Raeppel, Stephane</creatorcontrib><creatorcontrib>Zhou, Nancy</creatorcontrib><creatorcontrib>Bouchain, Giliane</creatorcontrib><creatorcontrib>Woo, Soon Hyung</creatorcontrib><creatorcontrib>Jin, Zhiyun</creatorcontrib><creatorcontrib>Gillespie, Jeff</creatorcontrib><creatorcontrib>Wang, James</creatorcontrib><creatorcontrib>Fournel, Marielle</creatorcontrib><creatorcontrib>Yan, Pu Theresa</creatorcontrib><creatorcontrib>Trachy-Bourget, Marie-Claude</creatorcontrib><creatorcontrib>Robert, Marie-France</creatorcontrib><creatorcontrib>Lu, Aihua</creatorcontrib><creatorcontrib>Yuk, Jimmy</creatorcontrib><creatorcontrib>Rahil, Jubrail</creatorcontrib><creatorcontrib>MacLeod, A. Robert</creatorcontrib><creatorcontrib>Besterman, Jeffrey M.</creatorcontrib><creatorcontrib>Li, Zuomei</creatorcontrib><creatorcontrib>Delorme, Daniel</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vaisburg, Arkadii</au><au>Paquin, Isabelle</au><au>Bernstein, Naomy</au><au>Frechette, Sylvie</au><au>Gaudette, Frederic</au><au>Leit, Silvana</au><au>Moradei, Oscar</au><au>Raeppel, Stephane</au><au>Zhou, Nancy</au><au>Bouchain, Giliane</au><au>Woo, Soon Hyung</au><au>Jin, Zhiyun</au><au>Gillespie, Jeff</au><au>Wang, James</au><au>Fournel, Marielle</au><au>Yan, Pu Theresa</au><au>Trachy-Bourget, Marie-Claude</au><au>Robert, Marie-France</au><au>Lu, Aihua</au><au>Yuk, Jimmy</au><au>Rahil, Jubrail</au><au>MacLeod, A. Robert</au><au>Besterman, Jeffrey M.</au><au>Li, Zuomei</au><au>Delorme, Daniel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2007-12-15</date><risdate>2007</risdate><volume>17</volume><issue>24</issue><spage>6729</spage><epage>6733</epage><pages>6729-6733</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A variety of N-(2-amino-phenyl)-4-(heteroarylmethyl)-benzamides of general structure 10 were designed, synthesized, and evaluated as histone deacetylase (HDAC) inhibitors. A variety of N-(2-amino-phenyl)-4-(heteroarylmethyl)-benzamides were designed and synthesized. These compounds were shown to inhibit recombinant human HDAC1 with IC 50 values in the sub-micromolar range. In human cancer cells growing in culture these compounds induced hyperacetylation of histones, induced the expression of the tumor suppressor protein p21 WAF1/Cip1, and inhibited cellular proliferation. Certain compounds of this class also showed in vivo activity in various human tumor xenograft models in mice.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17977726</pmid><doi>10.1016/j.bmcl.2007.10.050</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2007-12, Vol.17 (24), p.6729-6733
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_68507276
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Amination
Animals
Antineoplastic agents
Benzamides
Benzamides - chemistry
Benzamides - pharmacology
Binding Sites
Biological and medical sciences
Cancer cell proliferation
Cell Line
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - pharmacology
General aspects
HDAC
Histone Deacetylase Inhibitors
Histone Deacetylases - chemistry
Histone Deacetylases - metabolism
Humans
Medical sciences
Methylation
Mice
Models, Molecular
Molecular Structure
Niacin - pharmacology
ortho-Aminobenzoates - chemistry
Pharmacology. Drug treatments
Structure-Activity Relationship
Urea - chemistry
Vasodilation - drug effects
title N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T20%3A45%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides%20as%20new%20histone%20deacetylase%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Vaisburg,%20Arkadii&rft.date=2007-12-15&rft.volume=17&rft.issue=24&rft.spage=6729&rft.epage=6733&rft.pages=6729-6733&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2007.10.050&rft_dat=%3Cproquest_cross%3E68507276%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19719363&rft_id=info:pmid/17977726&rft_els_id=S0960894X0701219X&rfr_iscdi=true